IBDEI0UL ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15088,1,4,0)
 ;;=4^V10.02
 ;;^UTILITY(U,$J,358.3,15088,1,5,0)
 ;;=5^H/O Oral Cavity/Pharynx Cancer
 ;;^UTILITY(U,$J,358.3,15088,2)
 ;;=^295204
 ;;^UTILITY(U,$J,358.3,15089,0)
 ;;=V10.43^^89^902^69
 ;;^UTILITY(U,$J,358.3,15089,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15089,1,4,0)
 ;;=4^V10.43
 ;;^UTILITY(U,$J,358.3,15089,1,5,0)
 ;;=5^H/O Ovarian Cancer
 ;;^UTILITY(U,$J,358.3,15089,2)
 ;;=^295221
 ;;^UTILITY(U,$J,358.3,15090,0)
 ;;=V10.46^^89^902^70
 ;;^UTILITY(U,$J,358.3,15090,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15090,1,4,0)
 ;;=4^V10.46
 ;;^UTILITY(U,$J,358.3,15090,1,5,0)
 ;;=5^H/O Prostate Cancer
 ;;^UTILITY(U,$J,358.3,15090,2)
 ;;=^295224
 ;;^UTILITY(U,$J,358.3,15091,0)
 ;;=V10.06^^89^902^71
 ;;^UTILITY(U,$J,358.3,15091,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15091,1,4,0)
 ;;=4^V10.06
 ;;^UTILITY(U,$J,358.3,15091,1,5,0)
 ;;=5^H/O Rectal/Anal Cancer
 ;;^UTILITY(U,$J,358.3,15091,2)
 ;;=^295208
 ;;^UTILITY(U,$J,358.3,15092,0)
 ;;=V10.52^^89^902^72
 ;;^UTILITY(U,$J,358.3,15092,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15092,1,4,0)
 ;;=4^V10.52
 ;;^UTILITY(U,$J,358.3,15092,1,5,0)
 ;;=5^H/O Renal Cancer
 ;;^UTILITY(U,$J,358.3,15092,2)
 ;;=H/o Renal Cancer^295229
 ;;^UTILITY(U,$J,358.3,15093,0)
 ;;=V10.04^^89^902^74
 ;;^UTILITY(U,$J,358.3,15093,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15093,1,4,0)
 ;;=4^V10.04
 ;;^UTILITY(U,$J,358.3,15093,1,5,0)
 ;;=5^H/O Stomach Cancer
 ;;^UTILITY(U,$J,358.3,15093,2)
 ;;=^295206
 ;;^UTILITY(U,$J,358.3,15094,0)
 ;;=V10.47^^89^902^75
 ;;^UTILITY(U,$J,358.3,15094,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15094,1,4,0)
 ;;=4^V10.47
 ;;^UTILITY(U,$J,358.3,15094,1,5,0)
 ;;=5^H/O Testicular Cancer
 ;;^UTILITY(U,$J,358.3,15094,2)
 ;;=^295225
 ;;^UTILITY(U,$J,358.3,15095,0)
 ;;=V10.83^^89^902^73
 ;;^UTILITY(U,$J,358.3,15095,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15095,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,15095,1,5,0)
 ;;=5^H/O Skin Cancer
 ;;^UTILITY(U,$J,358.3,15095,2)
 ;;=H/O Skin Cancer^295241
 ;;^UTILITY(U,$J,358.3,15096,0)
 ;;=285.22^^89^902^9
 ;;^UTILITY(U,$J,358.3,15096,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15096,1,4,0)
 ;;=4^285.22
 ;;^UTILITY(U,$J,358.3,15096,1,5,0)
 ;;=5^Anemia In Cancer
 ;;^UTILITY(U,$J,358.3,15096,2)
 ;;=^321978
 ;;^UTILITY(U,$J,358.3,15097,0)
 ;;=285.21^^89^902^10
 ;;^UTILITY(U,$J,358.3,15097,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15097,1,4,0)
 ;;=4^285.21
 ;;^UTILITY(U,$J,358.3,15097,1,5,0)
 ;;=5^Anemia In Renal Dis
 ;;^UTILITY(U,$J,358.3,15097,2)
 ;;=^321977
 ;;^UTILITY(U,$J,358.3,15098,0)
 ;;=285.29^^89^902^11
 ;;^UTILITY(U,$J,358.3,15098,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15098,1,4,0)
 ;;=4^285.29
 ;;^UTILITY(U,$J,358.3,15098,1,5,0)
 ;;=5^Anemia Of Chronic Dis
 ;;^UTILITY(U,$J,358.3,15098,2)
 ;;=^321979
 ;;^UTILITY(U,$J,358.3,15099,0)
 ;;=284.9^^89^902^12
 ;;^UTILITY(U,$J,358.3,15099,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15099,1,4,0)
 ;;=4^284.9
 ;;^UTILITY(U,$J,358.3,15099,1,5,0)
 ;;=5^Aplastic Anemia NOS
 ;;^UTILITY(U,$J,358.3,15099,2)
 ;;=^7020
 ;;^UTILITY(U,$J,358.3,15100,0)
 ;;=282.61^^89^902^78
 ;;^UTILITY(U,$J,358.3,15100,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15100,1,4,0)
 ;;=4^282.61
 ;;^UTILITY(U,$J,358.3,15100,1,5,0)
 ;;=5^Hemoglobin S Disease
 ;;^UTILITY(U,$J,358.3,15100,2)
 ;;=^267981
 ;;^UTILITY(U,$J,358.3,15101,0)
 ;;=282.7^^89^902^77
 ;;^UTILITY(U,$J,358.3,15101,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15101,1,4,0)
 ;;=4^282.7
 ;;^UTILITY(U,$J,358.3,15101,1,5,0)
 ;;=5^Hemoglobin C Disease
 ;;^UTILITY(U,$J,358.3,15101,2)
 ;;=^87629
